Computer-Aided Diagnostics Helps Accurately Determine Different Expression Levels of Claudin-18.2 in Gastric Cancer
Pathobiology · 2025
DOI: 10.1159/000545769 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathobiology, 2025. Verfasst von Sabina Köfler und 7 weiteren Autor:innen. Beteiligte Einrichtung: Johannes Kepler University Linz, Kepler University Hospital GmbH, Department of Pathology and Molecular Pathology, Linz, Austria. Hauptthemen laut MEDLINE: Stomach Neoplasms, Claudins, Diagnosis, Computer-Assisted, Biomarkers, Tumor. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Introduction
Determination of claudin-18.2 expression by immunohistochemistry (IHC) is a prerequisite for targeted treatment of gastric cancers (GCs) with zolbetuximab. Precise assessment of IHC expression categories, however, may be challenging and prone to interobserver variability. Computer-aided diagnosis has a high potential of improving diagnostic accuracy and reproducibility. We established a computer-aided analysis tool for claudin-18.2 positivity scoring.
Methods
Analysis steps included the identification of tumour tissue on haematoxylin-3,3′-diaminobenzidine-stained tissue microarray (TMA) slides, cell segmentation, and membranous staining intensity estimation of claudin-18.2 (clone 43-14A). We analysed 2,248 cores from 417 primary resected GCs with detailed pathological data available.
Results
In 51.6% (1,159/2,248) of TMA cores, no stained tumour cells were detected. Among cases with claudin-18.2 expression, predominantly 1+ and 2+ cells, a minority of 3+ stained cells were found, and 2+ to 3+ staining was unevenly distributed. Utilizing the SPOTLIGHT claudin-18.2 positivity threshold, we identified 12% (187/1,555) positive cores corresponding to 2.5% (9/365) positive cases. Lower staining intensities in tumour centre cores point to intratumoural heterogeneity.
Conclusion
Computer-aided diagnostics helps accurately measure claudin-18.2 expression levels, allowing to precisely determine claudin-18.2 status in GC patients. Previously uncaptured categorization of staining intensities may enhance the understanding of claudin-18.2 threshold for patient stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Johannes Kepler University Linz, Kepler University Hospital GmbH, Department of Pathology and Molecular Pathology, Linz, Austria.
- Department of Pathology, GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands.
- Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland.
- Department of Visceral Surgery and Medicine, Inselspital Bern, University of Bern, Bern, Switzerland.
Zitieren
APA
Köfler, S., Köfler, S., Mühlberger, K., Girkinger, V., Liu, D. H. W., Dislich, B., Gloor, B., & Langer, R. (2025). Computer-Aided Diagnostics Helps Accurately Determine Different Expression Levels of Claudin-18.2 in Gastric Cancer. Pathobiology. https://doi.org/10.1159/000545769
Vancouver
Köfler S, Köfler S, Mühlberger K, Girkinger V, Liu DHW, Dislich B, et al. Computer-Aided Diagnostics Helps Accurately Determine Different Expression Levels of Claudin-18.2 in Gastric Cancer. Pathobiology. 2025. doi:10.1159/000545769
BibTeX
@article{Kfler2025,
author = {Köfler, Sabina and Köfler, Sabina and Mühlberger, Katharina and Girkinger, Verena and Liu, Drolaiz H W and Dislich, Bastian and Gloor, Beat and Langer, Rupert},
title = {Computer-Aided Diagnostics Helps Accurately Determine Different Expression Levels of Claudin-18.2 in Gastric Cancer},
journal = {Pathobiology},
year = {2025},
doi = {10.1159/000545769}
}
EUVIMED